nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0237	0.121	CbGeAlD
Pramipexole—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0128	0.0653	CbGeAlD
Pramipexole—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0124	0.0633	CbGeAlD
Pramipexole—DRD1—nerve—amyotrophic lateral sclerosis	0.0081	0.0413	CbGeAlD
Pramipexole—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00744	0.00968	CcSEcCtD
Pramipexole—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00677	0.00881	CcSEcCtD
Pramipexole—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00663	0.00862	CcSEcCtD
Pramipexole—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00635	0.00826	CcSEcCtD
Pramipexole—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.00635	0.00826	CcSEcCtD
Pramipexole—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.00623	0.0081	CcSEcCtD
Pramipexole—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00616	0.0314	CbGeAlD
Pramipexole—HTR2A—pons—amyotrophic lateral sclerosis	0.00609	0.0311	CbGeAlD
Pramipexole—Yawning—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00764	CcSEcCtD
Pramipexole—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00577	0.0075	CcSEcCtD
Pramipexole—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00577	0.0075	CcSEcCtD
Pramipexole—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00724	CcSEcCtD
Pramipexole—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00724	CcSEcCtD
Pramipexole—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00712	CcSEcCtD
Pramipexole—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00519	0.0265	CbGeAlD
Pramipexole—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00637	CcSEcCtD
Pramipexole—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00637	CcSEcCtD
Pramipexole—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00637	CcSEcCtD
Pramipexole—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00628	CcSEcCtD
Pramipexole—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00628	CcSEcCtD
Pramipexole—DRD2—nerve—amyotrophic lateral sclerosis	0.00479	0.0244	CbGeAlD
Pramipexole—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00476	0.0243	CbGeAlD
Pramipexole—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00619	CcSEcCtD
Pramipexole—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00619	CcSEcCtD
Pramipexole—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0061	CcSEcCtD
Pramipexole—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0061	CcSEcCtD
Pramipexole—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0061	CcSEcCtD
Pramipexole—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0045	0.00585	CcSEcCtD
Pramipexole—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0045	0.00585	CcSEcCtD
Pramipexole—HTR2A—appendage—amyotrophic lateral sclerosis	0.00446	0.0227	CbGeAlD
Pramipexole—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00563	CcSEcCtD
Pramipexole—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00556	CcSEcCtD
Pramipexole—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00549	CcSEcCtD
Pramipexole—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00536	CcSEcCtD
Pramipexole—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0053	CcSEcCtD
Pramipexole—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00405	0.0207	CbGeAlD
Pramipexole—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00523	CcSEcCtD
Pramipexole—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00397	0.0202	CbGeAlD
Pramipexole—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00512	CcSEcCtD
Pramipexole—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00512	CcSEcCtD
Pramipexole—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00506	CcSEcCtD
Pramipexole—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00385	0.005	CcSEcCtD
Pramipexole—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00377	0.0049	CcSEcCtD
Pramipexole—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00377	0.0049	CcSEcCtD
Pramipexole—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00484	CcSEcCtD
Pramipexole—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00484	CcSEcCtD
Pramipexole—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00479	CcSEcCtD
Pramipexole—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00475	CcSEcCtD
Pramipexole—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00361	0.0047	CcSEcCtD
Pramipexole—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00361	0.0047	CcSEcCtD
Pramipexole—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00361	0.0047	CcSEcCtD
Pramipexole—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00359	0.0183	CbGeAlD
Pramipexole—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00456	CcSEcCtD
Pramipexole—DRD1—brainstem—amyotrophic lateral sclerosis	0.00348	0.0177	CbGeAlD
Pramipexole—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00452	CcSEcCtD
Pramipexole—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00452	CcSEcCtD
Pramipexole—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00452	CcSEcCtD
Pramipexole—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00447	CcSEcCtD
Pramipexole—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00443	CcSEcCtD
Pramipexole—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00435	CcSEcCtD
Pramipexole—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00435	CcSEcCtD
Pramipexole—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00435	CcSEcCtD
Pramipexole—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00435	CcSEcCtD
Pramipexole—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00431	CcSEcCtD
Pramipexole—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00431	CcSEcCtD
Pramipexole—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00427	CcSEcCtD
Pramipexole—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00427	CcSEcCtD
Pramipexole—Mania—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00423	CcSEcCtD
Pramipexole—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00416	CcSEcCtD
Pramipexole—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00412	CcSEcCtD
Pramipexole—HTR2A—nerve—amyotrophic lateral sclerosis	0.00316	0.0161	CbGeAlD
Pramipexole—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00409	CcSEcCtD
Pramipexole—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00409	CcSEcCtD
Pramipexole—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00402	CcSEcCtD
Pramipexole—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00395	CcSEcCtD
Pramipexole—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00389	CcSEcCtD
Pramipexole—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00383	CcSEcCtD
Pramipexole—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0038	CcSEcCtD
Pramipexole—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0038	CcSEcCtD
Pramipexole—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00374	CcSEcCtD
Pramipexole—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00371	CcSEcCtD
Pramipexole—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00282	0.0144	CbGeAlD
Pramipexole—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00363	CcSEcCtD
Pramipexole—DRD4—brain—amyotrophic lateral sclerosis	0.00277	0.0141	CbGeAlD
Pramipexole—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00358	CcSEcCtD
Pramipexole—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00273	0.0139	CbGeAlD
Pramipexole—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00353	CcSEcCtD
Pramipexole—HTR2C—brainstem—amyotrophic lateral sclerosis	0.0027	0.0138	CbGeAlD
Pramipexole—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0035	CcSEcCtD
Pramipexole—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00348	CcSEcCtD
Pramipexole—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00343	CcSEcCtD
Pramipexole—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00341	CcSEcCtD
Pramipexole—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00338	CcSEcCtD
Pramipexole—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00336	CcSEcCtD
Pramipexole—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00332	CcSEcCtD
Pramipexole—DRD3—nervous system—amyotrophic lateral sclerosis	0.00255	0.013	CbGeAlD
Pramipexole—Gout—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0033	CcSEcCtD
Pramipexole—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00327	CcSEcCtD
Pramipexole—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00325	CcSEcCtD
Pramipexole—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00325	CcSEcCtD
Pramipexole—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00323	CcSEcCtD
Pramipexole—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00245	0.0125	CbGeAlD
Pramipexole—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00315	CcSEcCtD
Pramipexole—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00313	CcSEcCtD
Pramipexole—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00313	CcSEcCtD
Pramipexole—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00312	CcSEcCtD
Pramipexole—DRD5—nervous system—amyotrophic lateral sclerosis	0.00239	0.0122	CbGeAlD
Pramipexole—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00308	CcSEcCtD
Pramipexole—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00308	CcSEcCtD
Pramipexole—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00237	0.0121	CbGeAlD
Pramipexole—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00304	CcSEcCtD
Pramipexole—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00304	CcSEcCtD
Pramipexole—DRD5—central nervous system—amyotrophic lateral sclerosis	0.0023	0.0117	CbGeAlD
Pramipexole—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00297	CcSEcCtD
Pramipexole—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00297	CcSEcCtD
Pramipexole—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00227	0.0116	CbGeAlD
Pramipexole—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00294	CcSEcCtD
Pramipexole—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00292	CcSEcCtD
Pramipexole—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00289	CcSEcCtD
Pramipexole—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00283	CcSEcCtD
Pramipexole—Coma—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00281	CcSEcCtD
Pramipexole—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00278	CcSEcCtD
Pramipexole—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00278	CcSEcCtD
Pramipexole—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00274	CcSEcCtD
Pramipexole—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00207	0.0027	CcSEcCtD
Pramipexole—DRD2—brainstem—amyotrophic lateral sclerosis	0.00206	0.0105	CbGeAlD
Pramipexole—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00267	CcSEcCtD
Pramipexole—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00264	CcSEcCtD
Pramipexole—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00262	CcSEcCtD
Pramipexole—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00262	CcSEcCtD
Pramipexole—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00259	CcSEcCtD
Pramipexole—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00257	CcSEcCtD
Pramipexole—DRD3—brain—amyotrophic lateral sclerosis	0.00195	0.00992	CbGeAlD
Pramipexole—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0025	CcSEcCtD
Pramipexole—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0025	CcSEcCtD
Pramipexole—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00249	CcSEcCtD
Pramipexole—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00246	CcSEcCtD
Pramipexole—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00188	0.00961	CbGeAlD
Pramipexole—Injury—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00243	CcSEcCtD
Pramipexole—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00241	CcSEcCtD
Pramipexole—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00238	CcSEcCtD
Pramipexole—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00238	CcSEcCtD
Pramipexole—DRD5—brain—amyotrophic lateral sclerosis	0.00182	0.0093	CbGeAlD
Pramipexole—DRD1—nervous system—amyotrophic lateral sclerosis	0.00182	0.0093	CbGeAlD
Pramipexole—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00236	CcSEcCtD
Pramipexole—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00235	CcSEcCtD
Pramipexole—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00232	CcSEcCtD
Pramipexole—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0023	CcSEcCtD
Pramipexole—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00229	CcSEcCtD
Pramipexole—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00176	0.00895	CbGeAlD
Pramipexole—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00175	0.00894	CbGeAlD
Pramipexole—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00224	CcSEcCtD
Pramipexole—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00223	CcSEcCtD
Pramipexole—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00223	CcSEcCtD
Pramipexole—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00223	CcSEcCtD
Pramipexole—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00222	CcSEcCtD
Pramipexole—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0022	CcSEcCtD
Pramipexole—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0022	CcSEcCtD
Pramipexole—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00168	0.00857	CbGeAlD
Pramipexole—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00218	CcSEcCtD
Pramipexole—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00216	CcSEcCtD
Pramipexole—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00212	CcSEcCtD
Pramipexole—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00212	CcSEcCtD
Pramipexole—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00212	CcSEcCtD
Pramipexole—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0021	CcSEcCtD
Pramipexole—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00208	CcSEcCtD
Pramipexole—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00204	CcSEcCtD
Pramipexole—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00203	CcSEcCtD
Pramipexole—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00202	CcSEcCtD
Pramipexole—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00198	CcSEcCtD
Pramipexole—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00197	CcSEcCtD
Pramipexole—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00194	CcSEcCtD
Pramipexole—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00193	CcSEcCtD
Pramipexole—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00193	CcSEcCtD
Pramipexole—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00193	CcSEcCtD
Pramipexole—HTR2A—embryo—amyotrophic lateral sclerosis	0.00148	0.00754	CbGeAlD
Pramipexole—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00148	0.00753	CbGeAlD
Pramipexole—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00189	CcSEcCtD
Pramipexole—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00188	CcSEcCtD
Pramipexole—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00144	0.00736	CbGeAlD
Pramipexole—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00143	0.00729	CbGeAlD
Pramipexole—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00186	CcSEcCtD
Pramipexole—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00185	CcSEcCtD
Pramipexole—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00142	0.00725	CbGeAlD
Pramipexole—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00142	0.00722	CbGeAlD
Pramipexole—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00141	0.00721	CbGeAlD
Pramipexole—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00139	0.00711	CbGeAlD
Pramipexole—DRD1—brain—amyotrophic lateral sclerosis	0.00139	0.0071	CbGeAlD
Pramipexole—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00139	0.00708	CbGeAlD
Pramipexole—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00181	CcSEcCtD
Pramipexole—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00138	0.00702	CbGeAlD
Pramipexole—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00178	CcSEcCtD
Pramipexole—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00178	CcSEcCtD
Pramipexole—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00695	CbGeAlD
Pramipexole—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00136	0.00691	CbGeAlD
Pramipexole—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00176	CcSEcCtD
Pramipexole—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00176	CcSEcCtD
Pramipexole—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00175	CcSEcCtD
Pramipexole—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00173	CcSEcCtD
Pramipexole—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00133	0.00678	CbGeAlD
Pramipexole—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00172	CcSEcCtD
Pramipexole—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00172	CcSEcCtD
Pramipexole—Depression—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00172	CcSEcCtD
Pramipexole—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0017	CcSEcCtD
Pramipexole—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00169	CcSEcCtD
Pramipexole—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00169	CcSEcCtD
Pramipexole—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00167	CcSEcCtD
Pramipexole—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00128	0.00653	CbGeAlD
Pramipexole—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00165	CcSEcCtD
Pramipexole—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00164	CcSEcCtD
Pramipexole—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00163	CcSEcCtD
Pramipexole—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00162	CcSEcCtD
Pramipexole—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00124	0.00634	CbGeAlD
Pramipexole—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00162	CcSEcCtD
Pramipexole—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00157	CcSEcCtD
Pramipexole—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00119	0.00608	CbGeAlD
Pramipexole—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00155	CcSEcCtD
Pramipexole—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00154	CcSEcCtD
Pramipexole—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00154	CcSEcCtD
Pramipexole—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00153	CcSEcCtD
Pramipexole—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00153	CcSEcCtD
Pramipexole—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00152	CcSEcCtD
Pramipexole—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00152	CcSEcCtD
Pramipexole—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00152	CcSEcCtD
Pramipexole—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00115	0.00585	CbGeAlD
Pramipexole—HTR1B—brain—amyotrophic lateral sclerosis	0.00113	0.00576	CbGeAlD
Pramipexole—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00112	0.00572	CbGeAlD
Pramipexole—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00111	0.00567	CbGeAlD
Pramipexole—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00144	CcSEcCtD
Pramipexole—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00143	CcSEcCtD
Pramipexole—SLC22A1—brain—amyotrophic lateral sclerosis	0.0011	0.00562	CbGeAlD
Pramipexole—HTR1D—brain—amyotrophic lateral sclerosis	0.00109	0.00557	CbGeAlD
Pramipexole—HTR2C—brain—amyotrophic lateral sclerosis	0.00108	0.00552	CbGeAlD
Pramipexole—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0014	CcSEcCtD
Pramipexole—DRD2—nervous system—amyotrophic lateral sclerosis	0.00108	0.00549	CbGeAlD
Pramipexole—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0014	CcSEcCtD
Pramipexole—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00139	CcSEcCtD
Pramipexole—Chills—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00139	CcSEcCtD
Pramipexole—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00137	CcSEcCtD
Pramipexole—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00105	0.00534	CbGeAlD
Pramipexole—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00135	CcSEcCtD
Pramipexole—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00104	0.00529	CbGeAlD
Pramipexole—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00135	CcSEcCtD
Pramipexole—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00133	CcSEcCtD
Pramipexole—HTR2B—brain—amyotrophic lateral sclerosis	0.00102	0.00518	CbGeAlD
Pramipexole—Tension—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00132	CcSEcCtD
Pramipexole—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00101	0.00517	CbGeAlD
Pramipexole—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00132	CcSEcCtD
Pramipexole—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00101	0.00514	CbGeAlD
Pramipexole—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00131	CcSEcCtD
Pramipexole—Back pain—Riluzole—amyotrophic lateral sclerosis	0.001	0.0013	CcSEcCtD
Pramipexole—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000995	0.00129	CcSEcCtD
Pramipexole—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000991	0.00506	CbGeAlD
Pramipexole—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000985	0.00502	CbGeAlD
Pramipexole—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00097	0.00126	CcSEcCtD
Pramipexole—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00096	0.00125	CcSEcCtD
Pramipexole—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000956	0.00124	CcSEcCtD
Pramipexole—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000951	0.00124	CcSEcCtD
Pramipexole—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000945	0.00482	CbGeAlD
Pramipexole—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00121	CcSEcCtD
Pramipexole—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00093	0.00121	CcSEcCtD
Pramipexole—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000928	0.00121	CcSEcCtD
Pramipexole—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000926	0.0012	CcSEcCtD
Pramipexole—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000914	0.00119	CcSEcCtD
Pramipexole—HTR1A—brain—amyotrophic lateral sclerosis	0.000911	0.00465	CbGeAlD
Pramipexole—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00091	0.00118	CcSEcCtD
Pramipexole—Cough—Riluzole—amyotrophic lateral sclerosis	0.000903	0.00117	CcSEcCtD
Pramipexole—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00117	CcSEcCtD
Pramipexole—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000893	0.00116	CcSEcCtD
Pramipexole—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000881	0.00115	CcSEcCtD
Pramipexole—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000881	0.00115	CcSEcCtD
Pramipexole—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000881	0.00115	CcSEcCtD
Pramipexole—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000878	0.00114	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000875	0.00114	CcSEcCtD
Pramipexole—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00087	0.00113	CcSEcCtD
Pramipexole—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000862	0.00112	CcSEcCtD
Pramipexole—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000852	0.00111	CcSEcCtD
Pramipexole—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000845	0.0011	CcSEcCtD
Pramipexole—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000843	0.0043	CbGeAlD
Pramipexole—Infection—Riluzole—amyotrophic lateral sclerosis	0.000839	0.00109	CcSEcCtD
Pramipexole—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000835	0.00426	CbGeAlD
Pramipexole—Shock—Riluzole—amyotrophic lateral sclerosis	0.000831	0.00108	CcSEcCtD
Pramipexole—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000828	0.00108	CcSEcCtD
Pramipexole—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000827	0.00108	CcSEcCtD
Pramipexole—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000824	0.00107	CcSEcCtD
Pramipexole—DRD2—brain—amyotrophic lateral sclerosis	0.000823	0.0042	CbGeAlD
Pramipexole—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00107	CcSEcCtD
Pramipexole—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000816	0.00106	CcSEcCtD
Pramipexole—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000805	0.00105	CcSEcCtD
Pramipexole—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000804	0.0041	CbGeAlD
Pramipexole—ADRA2C—brain—amyotrophic lateral sclerosis	0.0008	0.00408	CbGeAlD
Pramipexole—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000789	0.00103	CcSEcCtD
Pramipexole—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000786	0.00401	CbGeAlD
Pramipexole—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000769	0.001	CcSEcCtD
Pramipexole—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000764	0.000993	CcSEcCtD
Pramipexole—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000758	0.000986	CcSEcCtD
Pramipexole—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000753	0.000979	CcSEcCtD
Pramipexole—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000751	0.000976	CcSEcCtD
Pramipexole—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000743	0.000967	CcSEcCtD
Pramipexole—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000734	0.000955	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000729	0.000948	CcSEcCtD
Pramipexole—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000728	0.000947	CcSEcCtD
Pramipexole—Pain—Riluzole—amyotrophic lateral sclerosis	0.000722	0.000939	CcSEcCtD
Pramipexole—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000722	0.000939	CcSEcCtD
Pramipexole—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00071	0.00362	CbGeAlD
Pramipexole—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000696	0.000905	CcSEcCtD
Pramipexole—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000691	0.000898	CcSEcCtD
Pramipexole—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000684	0.00349	CbGeAlD
Pramipexole—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000671	0.000872	CcSEcCtD
Pramipexole—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000668	0.00341	CbGeAlD
Pramipexole—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000668	0.000868	CcSEcCtD
Pramipexole—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000668	0.000868	CcSEcCtD
Pramipexole—ADRA2A—brain—amyotrophic lateral sclerosis	0.000639	0.00326	CbGeAlD
Pramipexole—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000622	0.000809	CcSEcCtD
Pramipexole—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000606	0.000788	CcSEcCtD
Pramipexole—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000598	0.000777	CcSEcCtD
Pramipexole—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000578	0.000751	CcSEcCtD
Pramipexole—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000558	0.000726	CcSEcCtD
Pramipexole—HTR2A—brain—amyotrophic lateral sclerosis	0.000543	0.00277	CbGeAlD
Pramipexole—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000537	0.000698	CcSEcCtD
Pramipexole—Rash—Riluzole—amyotrophic lateral sclerosis	0.000533	0.000692	CcSEcCtD
Pramipexole—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000532	0.000692	CcSEcCtD
Pramipexole—Headache—Riluzole—amyotrophic lateral sclerosis	0.000529	0.000688	CcSEcCtD
Pramipexole—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000502	0.000652	CcSEcCtD
Pramipexole—HTR1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.52e-05	0.000726	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.48e-05	0.000714	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.47e-05	0.000712	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.45e-05	0.000705	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.45e-05	0.000704	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.44e-05	0.000702	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.43e-05	0.000701	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.42e-05	0.000697	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.4e-05	0.00069	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.39e-05	0.000687	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.38e-05	0.000684	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.37e-05	0.000682	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.36e-05	0.00068	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.36e-05	0.00068	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.35e-05	0.000676	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.34e-05	0.000673	CbGpPWpGaD
Pramipexole—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.33e-05	0.00067	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.32e-05	0.000669	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.31e-05	0.000665	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.3e-05	0.000663	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.3e-05	0.000661	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.29e-05	0.000659	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.29e-05	0.000658	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.27e-05	0.000652	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.26e-05	0.000651	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.25e-05	0.000649	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.23e-05	0.000643	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	2.22e-05	0.000639	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.2e-05	0.000634	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.18e-05	0.000628	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.18e-05	0.000626	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.17e-05	0.000625	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.15e-05	0.000619	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.13e-05	0.000613	CbGpPWpGaD
Pramipexole—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	2.12e-05	0.00061	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.11e-05	0.000608	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.1e-05	0.000603	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.1e-05	0.000603	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.07e-05	0.000597	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.06e-05	0.000594	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.05e-05	0.000589	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.04e-05	0.000587	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.04e-05	0.000587	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.04e-05	0.000587	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.03e-05	0.000584	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2e-05	0.000576	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2e-05	0.000576	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2e-05	0.000575	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.99e-05	0.000573	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.97e-05	0.000568	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.97e-05	0.000566	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.96e-05	0.000565	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.94e-05	0.000559	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.92e-05	0.000553	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.91e-05	0.00055	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.91e-05	0.00055	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.9e-05	0.000547	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.89e-05	0.000543	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.88e-05	0.00054	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.88e-05	0.00054	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.87e-05	0.000539	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.86e-05	0.000536	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.86e-05	0.000535	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.86e-05	0.000534	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.84e-05	0.000529	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.81e-05	0.00052	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.8e-05	0.000519	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.79e-05	0.000514	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.77e-05	0.000509	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.75e-05	0.000502	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.74e-05	0.000502	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.74e-05	0.0005	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.73e-05	0.000499	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.71e-05	0.000491	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.69e-05	0.000486	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.69e-05	0.000485	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.69e-05	0.000485	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.68e-05	0.000484	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.68e-05	0.000483	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.66e-05	0.000479	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.66e-05	0.000479	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.66e-05	0.000478	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.63e-05	0.000469	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.62e-05	0.000467	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.61e-05	0.000464	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.6e-05	0.000461	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.58e-05	0.000455	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.58e-05	0.000454	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.57e-05	0.000452	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.00045	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.55e-05	0.000447	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.53e-05	0.000441	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	0.000441	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.53e-05	0.00044	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.52e-05	0.000438	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.51e-05	0.000436	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.51e-05	0.000435	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.51e-05	0.000435	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.51e-05	0.000434	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.51e-05	0.000434	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.5e-05	0.000432	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.48e-05	0.000425	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.47e-05	0.000424	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.47e-05	0.000423	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.45e-05	0.000417	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.44e-05	0.000415	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.44e-05	0.000415	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000414	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.42e-05	0.00041	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.42e-05	0.00041	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.41e-05	0.000405	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.4e-05	0.000404	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.4e-05	0.000403	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.39e-05	0.000399	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.39e-05	0.000399	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.38e-05	0.000398	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.37e-05	0.000395	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	0.00039	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.35e-05	0.000389	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.35e-05	0.000388	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000385	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.34e-05	0.000384	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.33e-05	0.000383	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.31e-05	0.000378	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.29e-05	0.000372	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.29e-05	0.00037	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.29e-05	0.00037	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.28e-05	0.000367	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.27e-05	0.000366	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.27e-05	0.000366	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.26e-05	0.000362	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.25e-05	0.00036	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.24e-05	0.000357	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000357	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.23e-05	0.000355	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.000348	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.2e-05	0.000346	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.2e-05	0.000345	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.2e-05	0.000345	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.2e-05	0.000344	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.2e-05	0.000344	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.19e-05	0.000343	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000341	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.18e-05	0.00034	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000336	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.16e-05	0.000334	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000329	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.14e-05	0.000328	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	0.000325	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	1.12e-05	0.000321	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.12e-05	0.000321	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	1.11e-05	0.00032	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000317	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	0.000315	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.09e-05	0.000313	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.07e-05	0.000308	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.07e-05	0.000307	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.07e-05	0.000307	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.06e-05	0.000306	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.06e-05	0.000306	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.04e-05	0.0003	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.03e-05	0.000297	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.03e-05	0.000295	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.02e-05	0.000295	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.000295	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.01e-05	0.00029	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.00029	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.97e-06	0.000287	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.94e-06	0.000286	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.78e-06	0.000281	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.75e-06	0.000281	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.6e-06	0.000276	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.55e-06	0.000275	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.29e-06	0.000267	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.22e-06	0.000265	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.17e-06	0.000264	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.1e-06	0.000262	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	9.07e-06	0.000261	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.06e-06	0.000261	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.05e-06	0.00026	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	9.02e-06	0.00026	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.9e-06	0.000256	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.43e-06	0.000242	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.29e-06	0.000239	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.21e-06	0.000236	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.18e-06	0.000235	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.1e-06	0.000233	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.01e-06	0.000231	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.93e-06	0.000228	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.89e-06	0.000227	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.88e-06	0.000227	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.82e-06	0.000225	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.73e-06	0.000223	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.67e-06	0.000221	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.61e-06	0.000219	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.57e-06	0.000218	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.54e-06	0.000217	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.53e-06	0.000217	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.45e-06	0.000214	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.29e-06	0.00021	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.11e-06	0.000205	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.1e-06	0.000204	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7e-06	0.000202	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.96e-06	0.0002	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.94e-06	0.0002	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.85e-06	0.000197	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.85e-06	0.000197	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.8e-06	0.000196	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.71e-06	0.000193	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.69e-06	0.000193	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.62e-06	0.00019	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.39e-06	0.000184	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.32e-06	0.000182	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.23e-06	0.000179	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.18e-06	0.000178	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.1e-06	0.000176	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.07e-06	0.000175	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.02e-06	0.000173	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.97e-06	0.000172	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.94e-06	0.000171	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.91e-06	0.00017	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.77e-06	0.000166	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.74e-06	0.000165	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.58e-06	0.000161	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.37e-06	0.000154	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.36e-06	0.000154	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.27e-06	0.000152	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.25e-06	0.000151	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.18e-06	0.000149	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.15e-06	0.000148	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.14e-06	0.000148	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.06e-06	0.000146	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.06e-06	0.000145	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.01e-06	0.000144	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.98e-06	0.000143	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.83e-06	0.000139	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.8e-06	0.000138	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.55e-06	0.000131	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.55e-06	0.000131	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.53e-06	0.00013	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.49e-06	0.000129	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.47e-06	0.000129	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.07e-06	0.000117	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.05e-06	0.000117	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.91e-06	0.000113	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.89e-06	0.000112	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.79e-06	0.000109	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.44e-06	9.89e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.38e-06	9.73e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.08e-06	8.85e-05	CbGpPWpGaD
